Clinical trials
Sarcopenia trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 8 |
| Enrolling by invitation | 3 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 5 |
| Federal University of Minas Gerais | 3 |
| Federal University of Uberlandia | 2 |
| Universidade Estadual de Londrina | 2 |
| AC Camargo Cancer Center | 1 |
| Barretos Cancer Hospital | 1 |
| Brazilian National Cancer Institute | 1 |
| Eduardo Ferriolli | 1 |
| Federal University of Health Science of Porto Alegre | 1 |
| Federal University of Juiz de Fora | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcopenia | 34 |
| Obesity | 6 |
| Malnutrition | 3 |
| Neoplasms | 3 |
| Muscular Atrophy | 2 |
| Body Weight | 1 |
| Bone Diseases, Metabolic | 1 |
| Cachexia | 1 |
| Colonic Neoplasms | 1 |
| Crohn Disease | 1 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.